Business Wire
BusinessAMD and Cisco link up on AI infrastructure in Saudi Arabia, lifting shares as details remain thinThe Apex TimesBusinessAdobe’s “$4 billion Saudi AI giveaway” spooks headlines, but investors shruggedThe Apex TimesBusinessBaird points to accelerating enterprise AI adoption as reason for bullish view on PalantirThe Apex TimesBusinessOracle’s Contracted Backlog Surpasses $600 Billion, Highlighting the Gap Between Promised Revenue and Market ValueThe Apex TimesBusinessExxon Mobil rises about 2% as oil rebounds, but misses a key Washington gas-price forumThe Apex TimesBusinessEnergy stocks lift as oil prices rise again, pulling Exxon Mobil and peers higherThe Apex TimesBusinessTim Cook’s Goodbye Note to Apple Staff Marks a 15-Year Run at the TopThe Apex TimesBusinessTesla’s revenue growth is narrowing the gap with General Motors, chart suggestsThe Apex TimesBusinessBank of America points to a shift in how gold is being positioned, Yahoo Finance reportsThe Apex TimesBusinessMeta and Alphabet’s exposure to Jio Platforms faces a valuation test as India’s IPO hype buildsThe Apex TimesBusinessCathie Wood’s Ark cuts AMD in a $124 million shift within its AI stock basket, Yahoo Finance reportsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessAMD and Cisco link up on AI infrastructure in Saudi Arabia, lifting shares as details remain thinThe Apex TimesBusinessAdobe’s “$4 billion Saudi AI giveaway” spooks headlines, but investors shruggedThe Apex TimesBusinessBaird points to accelerating enterprise AI adoption as reason for bullish view on PalantirThe Apex TimesBusinessOracle’s Contracted Backlog Surpasses $600 Billion, Highlighting the Gap Between Promised Revenue and Market ValueThe Apex TimesBusinessExxon Mobil rises about 2% as oil rebounds, but misses a key Washington gas-price forumThe Apex TimesBusinessEnergy stocks lift as oil prices rise again, pulling Exxon Mobil and peers higherThe Apex TimesBusinessTim Cook’s Goodbye Note to Apple Staff Marks a 15-Year Run at the TopThe Apex TimesBusinessTesla’s revenue growth is narrowing the gap with General Motors, chart suggestsThe Apex TimesBusinessBank of America points to a shift in how gold is being positioned, Yahoo Finance reportsThe Apex TimesBusinessMeta and Alphabet’s exposure to Jio Platforms faces a valuation test as India’s IPO hype buildsThe Apex TimesBusinessCathie Wood’s Ark cuts AMD in a $124 million shift within its AI stock basket, Yahoo Finance reportsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessAMD and Cisco link up on AI infrastructure in Saudi Arabia, lifting shares as details remain thinThe Apex TimesBusinessAdobe’s “$4 billion Saudi AI giveaway” spooks headlines, but investors shruggedThe Apex TimesBusinessBaird points to accelerating enterprise AI adoption as reason for bullish view on PalantirThe Apex TimesBusinessOracle’s Contracted Backlog Surpasses $600 Billion, Highlighting the Gap Between Promised Revenue and Market ValueThe Apex TimesBusinessExxon Mobil rises about 2% as oil rebounds, but misses a key Washington gas-price forumThe Apex TimesBusinessEnergy stocks lift as oil prices rise again, pulling Exxon Mobil and peers higherThe Apex TimesBusinessTim Cook’s Goodbye Note to Apple Staff Marks a 15-Year Run at the TopThe Apex TimesBusinessTesla’s revenue growth is narrowing the gap with General Motors, chart suggestsThe Apex TimesBusinessBank of America points to a shift in how gold is being positioned, Yahoo Finance reportsThe Apex TimesBusinessMeta and Alphabet’s exposure to Jio Platforms faces a valuation test as India’s IPO hype buildsThe Apex TimesBusinessCathie Wood’s Ark cuts AMD in a $124 million shift within its AI stock basket, Yahoo Finance reportsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessAMD and Cisco link up on AI infrastructure in Saudi Arabia, lifting shares as details remain thinThe Apex TimesBusinessAdobe’s “$4 billion Saudi AI giveaway” spooks headlines, but investors shruggedThe Apex TimesBusinessBaird points to accelerating enterprise AI adoption as reason for bullish view on PalantirThe Apex TimesBusinessOracle’s Contracted Backlog Surpasses $600 Billion, Highlighting the Gap Between Promised Revenue and Market ValueThe Apex TimesBusinessExxon Mobil rises about 2% as oil rebounds, but misses a key Washington gas-price forumThe Apex TimesBusinessEnergy stocks lift as oil prices rise again, pulling Exxon Mobil and peers higherThe Apex TimesBusinessTim Cook’s Goodbye Note to Apple Staff Marks a 15-Year Run at the TopThe Apex TimesBusinessTesla’s revenue growth is narrowing the gap with General Motors, chart suggestsThe Apex TimesBusinessBank of America points to a shift in how gold is being positioned, Yahoo Finance reportsThe Apex TimesBusinessMeta and Alphabet’s exposure to Jio Platforms faces a valuation test as India’s IPO hype buildsThe Apex TimesBusinessCathie Wood’s Ark cuts AMD in a $124 million shift within its AI stock basket, Yahoo Finance reportsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex Times
Back to front
Berkshire Hathaway Has Owned DaVita Inc. Since 2011, Tying Warren Buffett to a Kidney-Care Bet
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 30, 1:46 PM EDT

Berkshire Hathaway Has Owned DaVita Inc. Since 2011, Tying Warren Buffett to a Kidney-Care Bet

A Yahoo Finance roundup highlighted DaVita as one of Warren Buffett’s best long-term stock ideas, noting Berkshire Hathaway’s position in the dialysis provider dating back more than a decade.

Berkshire Hathaway has held a stake in DaVita Inc. since 2011, according to a Yahoo Finance market update published Monday. The piece framed DaVita as part of Warren Buffett’s longer-term stock thinking, a style that typically favors established businesses with durable demand rather than fast-moving themes.

DaVita, a publicly traded healthcare company listed on the New York Stock Exchange as DaVita Inc. (DVA), provides kidney care services, a sector where patients often require ongoing treatment. In general terms, that makes dialysis a recurring healthcare need, which is one of the reasons investors have historically viewed dialysis providers as businesses with steady demand profiles.

The Yahoo Finance note did not provide new disclosures about Berkshire’s stake or any changes to its size in the article. Instead, it focused on the longevity of the investment, underscoring that Berkshire has been a holder of DaVita since 2011. For market watchers, the emphasis on time is itself meaningful, since Berkshire’s approach tends to reduce the importance of near-term trading and place more weight on fundamentals that can play out over years.

Berkshire Hathaway, the Omaha-based conglomerate led by Buffett, is known for building concentrated positions in a handful of large public companies. When Berkshire buys, it often does so with the expectation of holding for a long period, provided the business continues to meet management and financial expectations. In this context, the reported 2011 start date places DaVita in the category of “held-through” investments, rather than recent portfolio experimentation.

Still, the Yahoo Finance article offered limited detail beyond the holding period. It did not specify the number of shares Berkshire owns, the current market value of the position, or whether Berkshire has trimmed or added shares during that time. It also did not disclose any company-specific performance benchmarks or financial targets that supported the original purchase or the continued ownership.

In the broader healthcare landscape, DaVita operates in a segment that can be shaped by reimbursement rules, regulatory scrutiny, and healthcare delivery economics. Those factors can influence profitability even when patient demand remains steady. For that reason, the persistence of an investor like Berkshire over a long window can announcement comfort with how the business is expected to navigate those pressures, though the Yahoo Finance post does not offer additional specifics about DaVita’s strategy or results.

Why It Matters

  • A documented holding period of more than a decade reinforces how Buffett’s approach tends to emphasize durability over short-term moves.
  • For investors tracking Berkshire’s portfolio, the DaVita holding helps frame which segments of healthcare the firm has been willing to underwrite for the long run.
  • The dialysis-and-kidney-care theme can remain sensitive to reimbursement and regulation, so sustained ownership can be a proxy for confidence in the business’s ability to operate through policy cycles.

Sources

Key Facts

  • Yahoo Finance reported that Berkshire Hathaway has held DaVita Inc. (NYSE: DVA) since 2011.
  • The Yahoo Finance update associated DaVita with Warren Buffett’s long-term stock selection framework, describing it as one of his best long-term stock ideas.
  • DaVita is a publicly traded healthcare company listed on the New York Stock Exchange under the ticker DVA.
  • The article did not provide new information in the update about the current size of Berkshire’s DaVita stake or any changes to the position.

Finance Related

Berkshire Hathaway Has Owned DaVita Inc. Since 2011, Tying Warren Buffett to a Kidney-Care Bet | The Apex Times